
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 956136-95-1 | 货号 | BCP21089 |
中文名 | LCQ-908 | ||
英文名 | LCQ-908 | ||
中文别名 | |||
英文别名 | LCQ908; LCQ 908; Pradigastat; | ||
SMILES | C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)C3=NC=C(C=C3)NC4=CN=C(C=C4)C(F)(F)F | ||
化学名称 | |||
分子式 | C25H24F3N3O2 | 分子量 | 455.48 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Pradigastat, also known as LCQ-908, is potent and oral DGAT1 inhibitor. Pradigastat is being developed for the treatment of familial chylomicronemia syndrome. Familial chylomicronemia syndrome (FCS) is a rare lipid disease caused by complete lipoprotein lipase (LPL) deficiency resulting in fasting chylomicronemia and severe hypertriglyceridemia. Inhibition of diacylglycerol acyltransferase 1 (DGAT1), which mediates chylomicron triglyceride (TG) synthesis, is an attractive strategy to reduce TG levels in FCS . |
相关产品推荐
查看更多 >Tags:LCQ-908 供应商,LCQ-908 购买,LCQ-908 生产,LCQ-908 批量,LCQ-908 供应,LCQ-908 订购,LCQ-908 采购